Cargando…

High Factor VIII Levels and Recurrent Thromboembolism in Patients with and without Inflammatory Bowel Disease: A Retrospective Comparative Study

Background The natural course of elevated factor VIII (FVIII) in patients with venous thromboembolism (VTE) and with or without inflammatory bowel disease (IBD) is not well described. Furthermore, the data on effectiveness and safety of extended anticoagulation in these patients are limited. Method...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eagle, G E., Schulman, Sam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192184/ https://www.ncbi.nlm.nih.gov/pubmed/35707621 http://dx.doi.org/10.1055/a-1827-7464

Ejemplares similares

Venous thromboembolism in inflammatory bowel disease
por: Cheng, Kimberly, et al.
Publicado: (2020)

Management of venous thromboembolism: an update
por: Piran, Siavash, et al.
Publicado: (2016)

Inflammatory bowel disease, such as Ulcerative colitis, is a risk factor for recurrent thromboembolic events: a case report
por: O'Connor, Mortimer B, et al.
Publicado: (2009)

Thromboembolic Events in Patients with Inflammatory Bowel Disease
por: Algahtani, Farjah H., et al.
Publicado: (2016)

Respiratory Review of 2013: Pulmonary Thromboembolism
por: Hwang, Hun Gyu, et al.
Publicado: (2013)

The incidence and risk factors of venous thromboembolism in Japanese inpatients with inflammatory bowel disease: a retrospective cohort study
por: Ando, Katsuyoshi, et al.
Publicado: (2018)

Elevated factor VIII level and stroke in patients without traditional risk factors associated with cardiovascular diseases
por: Anetta, Lasek-Bal, et al.
Publicado: (2013)

Recurrent Cerebral Venous Thrombosis Associated with Elevated Factor VIII
por: Kim, Mi Jung, et al.
Publicado: (2006)

Inflammatory bowel disease and superior mesenteric artery thromboembolism
por: Nicolaides, Steven, et al.
Publicado: (2020)

Venous and arterial thromboembolism in patients with inflammatory bowel diseases
por: Stadnicki, Antoni, et al.
Publicado: (2021)

Hypoalbuminemia as a risk factor for thromboembolic events in inflammatory bowel disease inpatients
por: Imbrizi, Marcello Rabello, et al.
Publicado: (2019)

Is the Risk for Venous Thromboembolism in East Asian Patients with Inflammatory Bowel Disease Comparable to That in Western Patients?
por: Hwang, Sung Wook
Publicado: (2022)

Upregulation of Coagulation Factor VIII and Fibrinogen After Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension
por: Myllylahti, Lasse, et al.
Publicado: (2023)

Comparative analysis of marketed factor VIII products: reply
por: Reipert, B. M., et al.
Publicado: (2018)

Venous Thromboembolism Prophylaxis in Inflammatory Bowel Disease: A Two-year Retrospective Study of Patients Presenting With Inflammatory Bowel Disease to a Community Hospital
por: Amakye, Dominic, et al.
Publicado: (2022)

Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis
por: Lopes, Luciane Cruz, et al.
Publicado: (2014)

High factor VIII levels and arterial thrombosis: illustrative case and literature review
por: Algahtani, Farjah Hassan, et al.
Publicado: (2019)

Thromboembolic tendency (TE) in IBD (inflammatory bowel disease) patients
por: Canero, A, et al.
Publicado: (2010)

Venous thromboembolism prophylaxis in inflammatory bowel disease flare-ups
por: Kaddourah, Osama, et al.
Publicado: (2019)

Recurrent gastrointestinal bleeding in a patient with Heyde syndrome with elevated factor VIII levels: A case report
por: Al-Radaideh, Omar, et al.
Publicado: (2021)

Factors affecting the recurrence in patients with venous thromboembolism: A retrospective cohort study
por: Ateş, Yasemin, et al.
Publicado: (2021)

Risk Factors of Venous Thromboembolism in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
por: Zhang, Hua, et al.
Publicado: (2021)

Thromboembolism in inflammatory bowel diseases: a report from Saudi Arabia
por: Issa, Hussain, et al.
Publicado: (2011)

Inflammatory bowel disease and thromboembolic events: a c’lot to learn
por: Carvalho, Ana Catarina, et al.
Publicado: (2022)

Thromboembolic Events in Patients with Inflammatory Bowel Disease: A Comprehensive Overview
por: Gala, Dhir, et al.
Publicado: (2022)

Factor VIII, Fibrinogen and Heparin Resistance in COVID-19 Patients with Thromboembolism: How Should We Manage the Anticoagulation Therapy?
por: Savioli, Felicio, et al.
Publicado: (2022)

FACTOR VIII COAGULANT ACTIVITY AND FACTOR VIII-LIKE ANTIGEN: INDEPENDENT MOLECULAR ENTITIES
por: Zimmerman, Theodore S., et al.
Publicado: (1973)

Comparative glycosylation mapping of plasma-derived and recombinant human factor VIII
por: Qu, Jingyao, et al.
Publicado: (2020)

Prophylaxis of Venous Thromboembolism in Patients with Infectious Disease
por: Hwang, Hun-Gyu, et al.
Publicado: (2020)

Repression of Factor VIII Inhibitor Development with Apoptotic Factor VIII-expressing Embryonic Stem Cells
por: Sakurai, Yoshihiko, et al.
Publicado: (2013)

Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery
por: Papa, Alfredo, et al.
Publicado: (2020)

Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel Disease
por: Setyawan, Juliana, et al.
Publicado: (2021)

Comparative analysis of activity of coagulation Factors V and VIII and level of fibrinogen in fresh frozen plasma and frozen plasma
por: Dogra, Mitu, et al.
Publicado: (2015)

Study on Coagulation Factor VIII and Fibrinogen Levels in Patients with Thyroid Disorders
por: Thoyyib, Muhammed, et al.
Publicado: (2018)

Hormonal contraceptives and venous thromboembolism: Are inflammatory bowel disease patients at increased risk? A retrospective study on a prospective database
por: Pellino, Gianluca, et al.
Publicado: (2015)

Factor VIII antibody immune complexes modulate the humoral response to factor VIII in an epitope-dependent manner
por: Batsuli, Glaivy, et al.
Publicado: (2023)

Verification and Comparison of Chromogenic Factor VIII Activity Assays in Patients With Hemophilia Treated With and Without Emicizumab
por: Lee, Min Young, et al.
Publicado: (2023)

Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism
por: Puhr, Hannah C., et al.
Publicado: (2019)

Platelet Function and Factor VIII in Uremia(*)
por: Park, Hee Sook, et al.
Publicado: (1987)

Tolerating Factor VIII: Recent Progress
por: Lacroix-Desmazes, Sebastien, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_grjcum6gcnp0p61h5g80475t54